Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 4.330
+0.045 (1.05%)
Jul 15, 2026, 4:25 PM CET
Thor Medical ASA Market Cap
Thor Medical ASA has a market cap or net worth of 1.56 billion as of July 15, 2026. Its market cap has increased by 75.51% in one year.
Market Cap
1.56B
Enterprise Value
1.55B
Revenue
839.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
4.33
Market Cap Chart
Since July 4, 2023, Thor Medical ASA's market cap has increased from 466.61M to 1.56B, an increase of 234.07%. That is a compound annual growth rate of 48.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 1.56B | -16.14% |
| Dec 30, 2025 | 1.86B | 151.99% |
| Dec 30, 2024 | 737.69M | 144.87% |
| Dec 29, 2023 | 301.27M | -35.44% |
| Jul 4, 2023 | 466.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 1.75B |
| ArcticZymes Technologies ASA | 975.46M |
| Nykode Therapeutics AS | 904.53M |
| Lytix Biopharma ASA | 767.46M |
| Zelluna ASA | 570.63M |
| Oncoinvent ASA | 338.57M |
| SoftOx Solutions AS | 245.09M |
| Arctic Bioscience AS | 85.99M |